Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Offering SPR-BLI Services - Proteins provided for free!
Thank you for choosing ACROBiosystems. Would you rate our product and service? Thank you for choosing ACROBiosystems. Would you rate our product and service?
Here come GMP Grade Cytokines!Free Sample is available! Here come GMP Grade Cytokines!Free Sample is available!
製造番号 | 種類 | 製品説明 | 構造 | 純度 | 特徴 |
---|---|---|---|---|---|
RSF-V52H4 | Mumps virus | Mumps virus (strain Miyahara vaccine) (MuV) Fusion glycoprotein F0, His Tag (MALS verified) |
|
The purity of Mumps virus (strain Miyahara vaccine) (MuV) Fusion glycoprotein F0, His Tag (Cat. No. RSF-V52H4) is more than 85% and the molecular weight of this protein is around 185-215 kDa verified by SEC-MALS.
Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Respiratory syncytial virus immune globulin | RSV-IGIV | Approved | Medimmune | RespiGam | Canada | Respiratory Syncytial Virus Infections | Medimmune Llc | 1996-01-01 | Respiratory Syncytial Virus Infections | Details |
Nirsevimab | Anti-RSV MAb-YTE; Anti-RSV-mAb-D25; SP-0232; MEDI-8897 | Approved | Aimm Therapeutics, Sanofi, MedImmune Inc | Beyfortus | EU | Respiratory Syncytial Virus Infections | Astrazeneca Ab | 2022-10-31 | Lower Respiratory Tract Infections; Respiratory Syncytial Virus Infections | Details |
Palivizumab | ABT-315; MEDI-493 | Approved | Abbvie Inc, Medimmune Llc | Synagis | Japan | Respiratory Syncytial Virus Infections | Abbvie Inc | 1998-06-19 | Bronchopulmonary Dysplasia; Respiratory Syncytial Virus Infections; Heart Defects, Congenital; Premature Birth; Infant, Premature, Diseases | Details |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Motavizumab biosimilar (MedImmune) | MEDI-557 | Medimmune Llc | Details | ||
Motavizumab | MEDI-524 | Medimmune Llc | Details | ||
CPI-RSV-F Vaccine | BLB-201 | Phase 1 Clinical | Blue Lake Biotechnology Inc | Respiratory Syncytial Virus Infections | Details |
Ziresovir | RO-0529; AK-0529 | Phase 3 Clinical | F. Hoffmann-La Roche Ltd | Respiratory Syncytial Virus Infections | Details |
This web search service is supported by Google Inc.